The study highlighted the potential interest of targeting the HSP70 interaction with other cells for cancer therapy [31]. Another study demonstrated the application of an HSP90 inhibitor in preclinical models of thyroid cancer. This evidence concerns the gene HSP90AA1 and thyroid cancer.